Fred Alger Management’s EnteroMedics Inc. ETRM Stock Holding History

Fred Alger Management’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,147	Closed	-$1.71M	–	806
2014 Q4	$1.71M	Buy	1,147 +366	+47%	+$494K	0.01%	403
2014 Q3	$1.01M	Buy	781 +161	+26%	+$236K	﹤0.01%	433
2014 Q2	$1.02M	Buy	+620	New	+$1.16M	0.01%	432

Other funds holding ETRM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCCM

Blue Clay Capital Management Minneapolis, Minnesota $88.7M AUM 6.88% 1-Year Est. Return

Fred Alger Management's ETRM Position: Q1 2015 in Review

Fred Alger Management sold out of EnteroMedics Inc. (ETRM) in Q1 2015, closing a stake of 1,147 shares — an estimated $1.71M sold.

Fred Alger Management first reported a position in ETRM in Q2 2014 and held it in 3 quarters. The position peaked at $1.71M in Q4 2014. 51 funds tracked by Wall St. Rank hold ETRM as of Q1 2015.

Fred Alger Management reported no remaining EnteroMedics Inc. position as of Q1 2015 after selling out during the quarter.
Fred Alger Management sold 1,147 EnteroMedics Inc. shares in Q1 2015, an estimated $1.71M.
Fred Alger Management first reported a position in EnteroMedics Inc. in Q2 2014 and held it in 3 quarters.
Fred Alger Management's EnteroMedics Inc. position peaked at $1.71M in Q4 2014.
51 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q1 2015.

Based on Fred Alger Management's 13F filing for Q1 2015, filed 15 May 2015.